Compare IMCC & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMCC | PPCB |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | Israel | Australia |
| Employees | N/A | 2 |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 1.9M |
| IPO Year | 2019 | N/A |
| Metric | IMCC | PPCB |
|---|---|---|
| Price | $0.38 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 196.3K | ★ 5.8M |
| Earning Date | 05-14-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $63.88 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $0.10 |
| 52 Week High | $7.12 | $10.69 |
| Indicator | IMCC | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 33.03 | 37.20 |
| Support Level | $0.30 | N/A |
| Resistance Level | $1.55 | $0.13 |
| Average True Range (ATR) | 0.06 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 35.43 | 6.27 |
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.